Aeterna Zentaris presents AEZS-131 data against tumor at AACR meeting Aeterna Zentaris Inc.

Aeterna Zentaris presents AEZS-131 data against tumor at AACR meeting Aeterna Zentaris Inc. Poster #3563 Entitled, ‘A highly selective Erk 1/2 inhibitor with in-vivo anti tumor potency’, Irene Seipelt, Eckhard Guenther, Lars Blumenstein, Gilbert Mueller, Peter Schmidt, Babette Aicher, Michael Teifel and Matthias Gerlach . In in vivo pharmacokinetic studies, AEZS-131 demonstrated a good PK profile. Anti-tumor activity was studied in in vivo mouse xenograft experiments utilizing the HCT-116 colon cancer model. AEZS-131 considerably inhibited tumor growth and was well tolerated at daily dosages up to 120 mg/kg.But that little change can build up and give you a better long-term result, because it isn’t as hard to do as giving up French fries forever. Certified from medwireNews with permission from Springer Health care Ltd. All rights reserved. Neither of the ongoing celebrations endorse or recommend any commercial products, services, or equipment.

3 Breast Cancer Remedies Explained Around 44,500 people are identified as having breast cancer each year. Although the precise cause continues to be unknown, we realize that it begins when the breast tissues start to multiply in a uncontrolled and rapid way. The symptoms of the type of cancer are often difficult to recognize but fortunately there are a variety of tests your physician can perform. In this post I will be discussing three of these tests.